vs

Side-by-side financial comparison of Fulgent Genetics, Inc. (FLGT) and Microvast Holdings, Inc. (MVST). Click either name above to swap in a different company.

Microvast Holdings, Inc. is the larger business by last-quarter revenue ($96.4M vs $71.1M, roughly 1.4× Fulgent Genetics, Inc.). On growth, Fulgent Genetics, Inc. posted the faster year-over-year revenue change (-3.2% vs -15.0%). Over the past eight quarters, Microvast Holdings, Inc.'s revenue compounded faster (8.9% CAGR vs 0.1%).

Fulgent Genetics, Inc. is a molecular diagnostics technology firm that develops and offers genetic testing services including carrier screening, oncology testing, infectious disease detection, and hereditary condition analysis, serving clinical providers, pharma firms, research institutions and public health groups primarily in North America.

Microvast Holdings, Inc. is a battery technology company headquartered in Stafford, Texas, and publicly traded on the NASDAQ Stock Exchange. It designs, develops and manufactures battery components and systems primarily for electric commercial vehicles and utility-scale energy storage systems (ESS). Microvast has manufacturing facilities in the United States, China, and Germany.

FLGT vs MVST — Head-to-Head

Bigger by revenue
MVST
MVST
1.4× larger
MVST
$96.4M
$71.1M
FLGT
Growing faster (revenue YoY)
FLGT
FLGT
+11.8% gap
FLGT
-3.2%
-15.0%
MVST
Faster 2-yr revenue CAGR
MVST
MVST
Annualised
MVST
8.9%
0.1%
FLGT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FLGT
FLGT
MVST
MVST
Revenue
$71.1M
$96.4M
Net Profit
$16.5M
Gross Margin
30.2%
1.0%
Operating Margin
21.1%
-42.7%
Net Margin
17.2%
Revenue YoY
-3.2%
-15.0%
Net Profit YoY
120.1%
EPS (diluted)
$0.04
$0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FLGT
FLGT
MVST
MVST
Q1 26
$71.1M
Q4 25
$83.3M
$96.4M
Q3 25
$84.1M
$123.3M
Q2 25
$81.8M
$91.3M
Q1 25
$73.5M
$116.5M
Q4 24
$76.2M
$113.4M
Q3 24
$71.7M
$101.4M
Q2 24
$71.0M
$83.7M
Net Profit
FLGT
FLGT
MVST
MVST
Q1 26
Q4 25
$-23.4M
$16.5M
Q3 25
$-6.6M
$-1.5M
Q2 25
$-19.0M
$-106.1M
Q1 25
$-11.5M
$61.8M
Q4 24
$-5.9M
$-82.3M
Q3 24
$-14.6M
$13.2M
Q2 24
$-8.7M
$-101.6M
Gross Margin
FLGT
FLGT
MVST
MVST
Q1 26
30.2%
Q4 25
39.1%
1.0%
Q3 25
42.2%
37.6%
Q2 25
42.1%
34.7%
Q1 25
38.6%
36.9%
Q4 24
41.8%
36.6%
Q3 24
37.3%
33.2%
Q2 24
37.3%
32.5%
Operating Margin
FLGT
FLGT
MVST
MVST
Q1 26
21.1%
Q4 25
-43.5%
-42.7%
Q3 25
-18.3%
10.5%
Q2 25
-24.1%
17.8%
Q1 25
-26.9%
16.3%
Q4 24
-21.2%
-1.2%
Q3 24
-23.8%
7.1%
Q2 24
-26.6%
-118.0%
Net Margin
FLGT
FLGT
MVST
MVST
Q1 26
Q4 25
-28.1%
17.2%
Q3 25
-7.9%
-1.2%
Q2 25
-23.2%
-116.1%
Q1 25
-15.7%
53.0%
Q4 24
-7.7%
-72.6%
Q3 24
-20.4%
13.1%
Q2 24
-12.3%
-121.4%
EPS (diluted)
FLGT
FLGT
MVST
MVST
Q1 26
$0.04
Q4 25
$0.19
Q3 25
$0.00
Q2 25
$-0.33
Q1 25
$0.05
Q4 24
$-0.24
Q3 24
$0.03
Q2 24
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FLGT
FLGT
MVST
MVST
Cash + ST InvestmentsLiquidity on hand
$23.4M
$105.0M
Total DebtLower is stronger
$13.2M
Stockholders' EquityBook value
$410.5M
Total Assets
$1.2B
$1.0B
Debt / EquityLower = less leverage
0.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FLGT
FLGT
MVST
MVST
Q1 26
$23.4M
Q4 25
$50.2M
$105.0M
Q3 25
$117.6M
$90.7M
Q2 25
$87.9M
$99.7M
Q1 25
$67.3M
$90.9M
Q4 24
$55.1M
$73.0M
Q3 24
$58.0M
$63.6M
Q2 24
$65.1M
$68.2M
Total Debt
FLGT
FLGT
MVST
MVST
Q1 26
Q4 25
$13.2M
Q3 25
$34.4M
Q2 25
$34.2M
Q1 25
$41.3M
Q4 24
$41.1M
Q3 24
$53.4M
Q2 24
$34.2M
Stockholders' Equity
FLGT
FLGT
MVST
MVST
Q1 26
Q4 25
$1.1B
$410.5M
Q3 25
$1.1B
$358.1M
Q2 25
$1.1B
$356.1M
Q1 25
$1.1B
$454.2M
Q4 24
$1.1B
$387.9M
Q3 24
$1.1B
$486.1M
Q2 24
$1.1B
$455.0M
Total Assets
FLGT
FLGT
MVST
MVST
Q1 26
$1.2B
Q4 25
$1.2B
$1.0B
Q3 25
$1.2B
$1.0B
Q2 25
$1.2B
$1.0B
Q1 25
$1.2B
$982.9M
Q4 24
$1.2B
$951.9M
Q3 24
$1.2B
$997.9M
Q2 24
$1.2B
$961.4M
Debt / Equity
FLGT
FLGT
MVST
MVST
Q1 26
Q4 25
0.03×
Q3 25
0.10×
Q2 25
0.10×
Q1 25
0.09×
Q4 24
0.11×
Q3 24
0.11×
Q2 24
0.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FLGT
FLGT
MVST
MVST
Operating Cash FlowLast quarter
$16.4M
Free Cash FlowOCF − Capex
$15.8M
FCF MarginFCF / Revenue
16.4%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
0.99×
TTM Free Cash FlowTrailing 4 quarters
$56.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FLGT
FLGT
MVST
MVST
Q1 26
Q4 25
$-78.1M
$16.4M
Q3 25
$11.1M
$15.2M
Q2 25
$-30.2M
$37.2M
Q1 25
$-4.4M
$7.2M
Q4 24
$25.0M
$6.1M
Q3 24
$-15.5M
$-5.4M
Q2 24
$4.3M
$111.0K
Free Cash Flow
FLGT
FLGT
MVST
MVST
Q1 26
Q4 25
$-83.1M
$15.8M
Q3 25
$5.1M
$1.2M
Q2 25
$-37.0M
$34.3M
Q1 25
$-9.1M
$4.8M
Q4 24
$21.2M
$5.7M
Q3 24
$-35.0M
$-19.6M
Q2 24
$-8.7M
$-2.8M
FCF Margin
FLGT
FLGT
MVST
MVST
Q1 26
Q4 25
-99.7%
16.4%
Q3 25
6.0%
1.0%
Q2 25
-45.2%
37.5%
Q1 25
-12.5%
4.1%
Q4 24
27.9%
5.1%
Q3 24
-48.8%
-19.3%
Q2 24
-12.2%
-3.4%
Capex Intensity
FLGT
FLGT
MVST
MVST
Q1 26
Q4 25
6.0%
0.7%
Q3 25
7.2%
11.3%
Q2 25
8.3%
3.1%
Q1 25
6.4%
2.0%
Q4 24
5.0%
0.3%
Q3 24
27.2%
14.0%
Q2 24
18.2%
3.5%
Cash Conversion
FLGT
FLGT
MVST
MVST
Q1 26
Q4 25
0.99×
Q3 25
Q2 25
Q1 25
0.12×
Q4 24
Q3 24
-0.41×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FLGT
FLGT

Segment breakdown not available.

MVST
MVST

Europe$35.1M36%
CN$32.5M34%
US$21.5M22%
Other$7.2M8%

Related Comparisons